Dr. Abdul-razaq Musa is a Paediatric Emergency Physician at the Women’s and Children’s Hospital in Australia, with a special interest in emergency mental health care and the advancement of paediatric resuscitation skills in low-resource settings. He is the founder of the International Resuscitation Group, Inc., a not-for-profit organization dedicated to improving paediatric resuscitation practices in developing countries. In 2014, Dr. Musa established the International Paediatric Life Support (IPLS) course, which now operates in 5 paediatric teaching hospitals and 3 medical colleges across Iraq and Australia. In addition to his medical and humanitarian work, Dr. Musa is a co-founder and currently serves as Chair of the Board at Playford College.

Adnan Sabir, M.S., RPh., is a Principal Consultant and Founder of “Pharma Consulting Services, Inc. (PCS)”, USA. He provides consultation in the Formulation and Process development, Scale-up and Tech Transfer, Regulatory issues, implementation of QbD/PAT, and Risk based development of products. He has significant hands-on and management experience and a proven track record for formulation and process development and Technology Transfer of pharmaceuticals from GSK, Solvay, Actavis, Kowa, and UCB. He also served as a VP of R&D at Dr. Reddy’s Lab establishing a product development / optimization operation. He has significant knowledge in Product development and manufacturing, CMC, cGMP, 21 CFR Part 11 and ICH Guidelines, and Serializations. He is a frequent speaker at various meetings in the United States, and other countries.

Forthcoming.

Forthcoming.

Forthcoming.

Forthcoming

Dr. Arshed A. Quyyumi, Former Global President of Medics International, has been involved in clinical translational research in cardiovascular diseases for over 25 years. Dr. Quyyumi received his undergraduate degree in Pharmacology and medical degree from the University of London, England. He completed his residency at Guy's and Royal Free Hospitals in London, and cardiology fellowships at National Heart Hospital, London; Massachusetts General Hospital, Harvard Medical School, Boston; and the National Institutes of Health. After completion of his residency and fellowship, he served in several capacities in the Cardiology Branch of National Heart Lung and Blood Institute, NIH in Bethesda, MD, including Senior Investigator and Director of the Cardiac Catheterization Laboratory. In 2001 he was appointed Professor of Medicine in the Division of Cardiology at Emory University School of Medicine, and in 2010 he was named Co-Director of the Emory Clinical Cardiovascular Research Institute (ECCRI). Since 2005, Dr. Quyyumi has been awarded more than $9 million in research funding. He serves on the Editorial Boards of several national journals, is a member on several Scientific Advisory Boards, and is a reviewer for the NIH-NHLBI Study Sections. Dr. Quyyumi has authored more than 250 peer-reviewed publications and has been an invited speaker and session chair at numerous National and International scientific meetings and conferences. Dr. Quyyumi's research focus includes vascular biology, angiogenesis, progenitor and stem cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease. Other interests have spanned the fields of personalized medicine and disparities in cardiovascular diseases. During his academic career, Dr. Quyyumi has carried out more than 50 NIH, industry-funded, or investigator-initiated projects, including numerous clinical trials. In addition to his phenomenal contribution to the profession of Cardiology in particular medicine in general, Dr. Quyyumi has vast contribution to the society in general and Medics International in particular serving at the Global Board of Regents. Dr. Quyyumi lives with his family in Atlanta, Georgia.

Dr. Azra Raza is the Chan Soon-Shiong Professor of Medicine, Clinical Director of the Evans Foundation MDS Center, and Executive Director of The First Cell Coalition for Cancer Survivors at Columbia University in New York. Dr. Raza completed her medical education in Pakistan, training in Internal Medicine at the University of Maryland, Franklin Square Hospital and Georgetown/VA Medical Center in Washington, D.C. and completed her fellowship in Medical Oncology at Roswell Park Cancer Institute in Buffalo, New York. She started her research in Myelodysplastic Syndromes (MDS) in 1984 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS program, along with a Tissue Repository containing more than 60,000 samples from MDS and acute leukemia patients was successfully relocated to Columbia University in 2010. Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cell, Cancer Cell, PNAS, Cancer, Cancer Research, British Journal of Hematology, Leukemia, Leukemia Research. Dr. Raza has mentored hundreds of medical students, residents, oncology fellows, doctoral and post-doctoral students in the last three decades. She serves on numerous National and International panels as a reviewer, consultant and advisor. Raza has collaborated on multiple high yielding large research projects with pharmaceutical companies including Celgene, Novartis, Regeneron and Grail Inc, and serves on the Board of GRAIL Inc. Raza is the recipient of a number of awards including The First Lifetime Achievement Award from APPNA, Award in Academic Excellence twice (2007 and 2010) from Dogana, and Woman of the Year Award from Safeer e Pakistan, CA, The Hope Award in Cancer Research 2012 (shared with the Nobel Laureate Dr. Elizabeth Blackburn) and the 2016 and 2019 Recognition Award from Developments in Literacy. Dr. Raza has been named as one of the 100 Women Who Matter by Newsweek Pakistan. In 2015, Dr. Raza was a member of the Founder Group at Jackson Hole, Wyoming, designing Breakthrough Developments in Science and Technology with President Bill Clinton. On December 1, 2015, Dr. Raza was part of a core group of cancer researchers who met with Vice President Joe Biden to discuss the Cancer Moonshot initiative. She is also the co-author of GHALIB: Epistemologies of Elegance, a book on the works of the famous Urdu poet. She believes that the best way to “tame the savageness of man and make gentle the life of this world” is by promoting and publicizing the achievements of humanity in science, art, and literature. She was married to the late Harvey D. Preisler, Director, Rush University Cancer Center in Chicago and has a daughter Sheherzad Raza Preisler who also lives in New York.

Professor Bagher Larijani was trained as an endocrinologist at Tehran University of Medical Sciences (TUMS) and obtained his Fellowship distinction from the American College of Endocrinology (FACE). He is the Founding President and Chief Scientific Officer of the Endocrinology and Metabolism Research Institute (EMRI), the largest medical research center in Iran with dozens of scientists and hundreds of employees. He is currently Professor of Medicine at TUMS and serves as Deputy Minister of Health. He has served as the Chancellor of Tehran University of Medical Sciences, the oldest and most prestigious medical school in Iran, and has held the position of the Chairman of the Policy-making Council at the Ministry of Health and Medical Education. In addition to his leadership role in Iranian medicine, Dr. Larijani continues to practice endocrinology and conducts clinical research. He has authored hundreds of journal articles and published several books in the fields of endocrinology, osteoporosis and medical ethics. With more than 16000 citations and an H-index of 68 recorded by Google Scholar in 2019, he is arguably the most prominent physician in Iran. Internationally, he has contributed to several global-scale research and policy-making conventions and assemblies, such as Lancet Commission on Obesity, and has been involved in different capacities in many projects of the International Osteoporosis Foundation, World Health Organization and other global health-related groups. It is noteworthy that during the past two decades, his main interest at the EMRI has been promoting pioneering translational medicine in Iran and bridging the gap between basic and clinical research in diabetes, osteoporosis, and other non-communicable diseases. Recently, as the Deputy-Chair of the National Supreme Committee for Prevention and Control of Non-communicable Diseases, Dr. Larijani has made significant contributions to design and development of national-scale, multi-sectoral policies aiming at controlling the rampant nation-wide increase in the burden of non-communicable diseases which is predicted to dramatically inflict the nation in the future.

Dr. Qusay B. Al-Zajaji is an adult endocrinologist and the Director of the Al-Hassan Specialized Metabolism, Endocrine, and Diabetes Center (HMEDC) in Karbala, Iraq. He holds multiple advanced qualifications, including board certifications from the Iraqi and Arab Boards in Internal Medicine, as well as a Master’s degree in Endocrinology, Diabetes, and Metabolism from the University of Basrah’s FDEMC. With extensive clinical and academic experience, Dr. Al-Zajaji serves as a mentor and supervisor for postgraduate trainees across Iraq and is an active member of several national and international endocrine societies. His research portfolio spans diabetes, thyroid disease, lipid disorders, pituitary and adrenal conditions, and endocrine metabolism, with numerous publications in regional and international journals. Dr. Al-Zajaji is a frequent speaker at major endocrinology and diabetes conferences and contributes significantly to scientific committees and medical education initiatives across Iraq and the broader region.

Dr. Fatema Jawad graduated from Dow Medical College, Karachi and did her training in Medicine in Karachi and in Diabetology at Bad Oeynhausen Germany. She received the FRCP from the Edinburgh University. She is heading the Diabetology department at Sind Institute of Urology and Transplantation, Karachi and has the credit of initiating live related renal transplantation in Patients with Diabetes and End Stage Renal Failure at SIUT. Dr. Jawad is also the editor–in-chief of the most prestigious and first pubmed indexed journal of Pakistan, Journal of Pakistan Medical Association (JPMA) since 2004. She has raised the standard of the journal which includes peer reviewed articles on all biomedical subjects. She has trained many junior professionals and medical students in the field of research and its publication. She is a founder member of the Pakistan Association of Medical Editors (PAME) and was the President for the term 2014 to 2016. She is a member of the World Association of Medical Editors (WAME) since 1996 and was elected as the Director WAME for the term, 2015 to 2017. She has 120 publications to her credit which includes book chapters.

Dr Fatima Zahra Aly is a board certified Cytopathologist and Surgical Pathologist with special interest in head and neck pathology as well as pulmonary pathology. She is currently a Professor at Wake Forest University in North Carolina, USA. She has mentored many graduate students and is actively involved in training residents and fellows in anatomic pathology. Her research interests include refining morphological diagnostic criteria, validation of instruments and immunohisto chemical tests as well as quality assurance as required by the Clinical Laboratory Improvement Amendments (CLIA) certification which is a US federal regulation ensuring the quality of all laboratory testing performed on humans in the United States

Forthcoming.

Forthcoming.

Forthcoming.

Dr. Iftekhar Bader is a pulmonologist in Racine, Wisconsin and is affiliated with multiple hospitals in the area, including Aurora St. Luke's Medical Center and Aurora Medical Center-Kenosha. He received his medical degree from Gandhi Medical College and has been in practice for more than 20 years.

Dr. Jaffer Syed graduated from the University of Toronto Medical School in 1998. After the completion of residency training and Clinical Fellowship in Interventional Cardiology, he has held various consultant and academic positions; currently Associate Clinical Professor in the Department of Medicine, McMaster University. He is passionate about medical education, and he continues to serve as teaching Faculty at the annual Interventional Cardiology Fellows’ Course, a meeting of national importance organized by the Canadian Association of Interventional Cardiology. Dr. Syed’s clinical interests include complex/high-risk coronary interventions and trans-catheter aortic valve implantation (TAVI). He is currently the Chief of Cardiology and Medical Director of the Cardiac Program at Waterloo Regional Health Network, Kitchener, Ontario, Canada. He also regularly volunteers with the IMI Arbaeen medical mission in Iraq.

Forthcoming.

Forthcoming.

Dr. Mazin Jawad Al Khabouri is a distinguished ENT (Ear, Nose, and Throat) surgeon specializing in cochlear implants. With a passion for restoring the gift of sound, Dr. Mazin Jawad Al Khabouri is renowned for his expertise in addressing complex auditory conditions with precision and compassion. Throughout his career, Dr. Mazin Jawad Al Khabouri has been at the forefront of innovation, embracing the latest advancements in ENT and cochlear implant technology. His commitment to excellence is matched only by his unwavering compassion for his patients, guiding them through every step of their treatment journey with empathy and understanding. Whether it's restoring hearing in infants born with congenital deafness or providing hope to adults experiencing progressive hearing loss, Dr. Mazin Jawad Al Khabouri is dedicated to helping his patients reclaim the joy of sound. Dr. Mazin Jawad Al Khabouri has served as the Director General of Directorate General of Private Health Establishments, Ministry of Health, Oman. Under his leadership private healthcare has witnessed exceptional transformation. He was spearheading the efforts of private healthcare during the fight against COVID-19 pandemic. He is also: Founder Member of Oman ENT Society Editorial Board Member for Journal of Oman Medical Association Founder Member of GCC ENT Society Founder Member of World Hearing Forum Member British Association of Pediatric Otolaryngologist (BAPO) Member Hearing International Dr. Mazin Jawad Al Khabouri has a rich experience of more than 4 decades. He has served as the head of department of ENT at Al Nahda Hospital, Muscat for almost 2 decades. He was advisor for Clinical Affairs to the Minister of Health. He has served as Director General of Directorate General Private Health Establishments for 6 years. Dr. Mazin Jawad Al Khabouri also served as Director General of Khoula Hospital, Muscat. He was the President of the Arab Board ENT Program. He has chaired the ENT Residency Training Program for 12 years. He is serving as Senior Clinical Lecturer College of Medicine at Sultan Qaboos University. He has served as World Health Organization consultant for Ear Care Program in developing countries.

He is a Professor of Internal Medicine at the University of Kufa College of Medicine and serves as the Scientific Director at Najaf Teaching Hospital. He plays a key role in advancing medical education in Iraq through his involvement in national and institutional accreditation bodies. He is a member of the National Council for Accreditation of Medical Colleges in Iraq, chairs the Program Accreditation Committee at the University of Kufa, and contributes to the university’s Research Committee for Institutional Accreditation. In addition, he leads the Internal Medicine Committee at the Department of Health, reflecting his commitment to both clinical excellence and academic leadership.

Forthcoming

Forthcoming

Dr Qarab Syed completed his medical education and graduated from Aga Khan University of Health Sciences, Karachi, Pakistan. He completed residency training in Internal Medicine and Cardiovascular Fellowship from State University of New York, NY. He has been practicing invasive cardiology for last twenty 4 years with board certifications in Internal Medicine, Cardiovascular disease, Nuclear Cardiology, Echocardiography, Vascular Medicine and Cardiac CT. He is serving as Chairman of Internal Medicine at Medina General Hospital of Cleveland Clinic, Director of Cardiac Cath lab and director of Ambulatory Cardiology services also at Cleveland clinic's regional hospital systems. He is also Assistant Professor of Medicine at the Lerner School of Medicine with Case Western Reserve University .

The doctor completed medical graduation in 1985, followed by a one-year internship and a two-year residency in Internal Medicine. In 1989, he joined the Sindh Institute of Urology and Transplantation (SIUT) as a trainee in Nephrology, later earning his postgraduate qualification while continuing with the institution. He received international clinical training at the Department of Renal Medicine and Transplantation at the Royal London Hospital and St. Bartholomew’s Hospital in London (1999–2000), and completed a prestigious one-year research fellowship awarded by the International Society of Nephrology at the Molecular Laboratory of Weill Medical College of Cornell University, New York (2004–2005). With over 33 years of dedicated service at SIUT—home to Asia’s largest hemodialysis program and the country’s largest live-related kidney transplant program—he has been serving as Professor of Nephrology since February 2011. His experience spans teaching undergraduate and postgraduate medical students, mentoring BS students in ethics, and supervising dissertations, theses, and research papers across multiple training leve

Dr. Sadiq Al-Sakini is a graduate of Baghdad University, Medical college in 1990. Had Master Degree in Pathology from Baghdad in 1995 and the fellowship of The Royal College of Pathologists of Australasia (RCPA) in 2007. Currently works as a specialist pathologist in Anatomical Pathology Service in Auckland and an Honorary Senior Lecturer – Molecular Medicine & Pathology, Auckland Medical School, New Zealand. Work includes dealing with histopathology and cytopathology with special interest in gynaecology pathology, including cervical screening cytology.

Forthcoming.

Shenaz Zaki Khaleeli with an M.Pharm. in (Pharmaceutics) and Ph.D. (Pharmacology) has over 34 years of experience as a Regulatory Professional with vast industry experience that encompasses the Innovator/MNC (10 years with AstraZeneca), Generics (Themis, Mumbai and Strides Arcolab, Bangalore) and is currently the principal consultant at Pharmaleaf, a Life Sciences company, thus giving her a truly composite industry perspective. Techno-commercial exposure across 1500+ projects that include research and development, registration and compliance, and commercialization of a portfolio of products ranging from biological, chemical, herbal, medical device, nutraceutical, veterinary, and cosmetics offerings for both regulated and emerging markets. With the unique distinction of managing control drugs, venturing into the domain of gene therapy, and radiopharmaceuticals, and supporting a myriad of newly regulated products driven by AI/ML. Collaborating with stakeholders i.e. Agencies, Scientific Bodies, Academia, Industry Associations (IDMA, OPPI), Embassies (trade bodies), Media, etc in a dynamic Pharma Regulatory environment to create awareness while proactively participating with national and international platforms that espouse the objective of convergence and harmonization of regulations/guidelines. A passionate trainer, recognized and acknowledged by academia, happy to share, from her vast repository of data and experience, has to her credit over 40 MPharm. thesis and a successful doctorate candidate who earned a Ph.D. in regulatory affairs. Her objective has been to train next-gen regulatory personnel to transit from being regulatory professionals to becoming regulatory practitioners. A founder-trustee of ZUN Foundation, the CSR initiative of Pharmaleaf, where her focus rests on a female-centric approach to healthcare, education, and family welfare. Her contribution to the industry as a women leader, regulatory expert, and entrepreneur has been duly acknowledged with Business Women of the Year, 2012 from PharmaLeader under the ministry of commerce and Pharmexcil for ongoing contribution to International Regulatory Affairs and Woman Entrepreneur Award from Maeshaat, 2013 a platform focusing on minorities business and economy. On her personal time, she is a voracious reader, a holistic lifestyle propagandist with an insatiated passion for travel, food and orchid gardens.

Forthcoming.

The Chancellor of IMI's al Sadiq International Virtual University (SIVU) and former Dean of the American University of Barbados, School of Medicine, Dr. Shabih Haider Zaidi completed his MBBS from Dow Medical College (DMC) in 1966. Following this he proceeded to UK for FRCS. He returned to Pakistan in 1972, and started teaching at his alma mater and rose to be the Professor and head of the department of ENT. He was also Principal of Sindh Medical College, Head of Medical Education, at DMC, Sindh Medical College and Jinnah Postgraduate Medical Center until 2001. Over the years, he was awarded Fellowships from of the American College of Surgeons (FACS), International College of Surgeons (FICS), and the College of Physicians and Surgeons, Pakistan (FCPS). Dr. Zaidi founded the Department of Medical Education at DMC. Dr. Zaidi has written several books and monographs, and published over a hundred scientific papers. He has also worked as an advisor and a consultant to the World Health Organization (WHO), and was a visiting Professor to the University Sains, Kelantan, Malaysia. Dr. Zaidi relocated to England in 2001 where he joined the University of Liverpool Teaching Hospital as an ENT Consultant. In 2004 he joined one of the University of Birmingham teaching NHS hospitals.

Dr. Syed Wajih Rizvi graduated from Dow Medical College, Karachi, Pakistan. He did his internal medicine residency at Thomas Jefferson University Hospital in Philadelphia, and then completed a fellowship in Endocrinology, Metabolism, and Lipid Disorders from the Medical College of Pennsylvania, Hahnemann University, and the University of Pennsylvania. For 8 years he headed the Endocrine Division of the Dakota Clinic and Innovis Health Systems in Fargo, ND, and was Associate Professor of Clinical Endocrinology at the University of North Dakota. Currently he is an Associate Professor, Clinical Endocrinology, at the University of Medicine and Dentistry of New Jersey, and Chief of R-Endocrinology and R-Research, in Hamilton, NJ. Dr. Rizvi is one of the founding members of Medics International, and serves as Advisor, International Relations & Affairs and the Permanent Representative to the United Nations and oversees the Global Headquarters. He has an avid interest in philosophy, Urdu poetry, traveling and wild life. He lives with his family in New Jersey.

Forthcoming.

Forthcoming

Medical graduate from Jabir Ibn Hayyan University (2024), with clinical and research experience. Holds certifications in BLS, ACLS, PALS, and MCI. Experienced in medical outreach and academic teaching on cardiology and pediatric topics. Professional interests include psychiatry, internal medicine and medical education, with a focus on compassionate, evidence-based care.